menu ☰
menu ˟

Eton’s FDA rejection leads July cornea news

09 Aug 2019
Cornea-related news in the month of July included FDA and clinical trial updates, but the most-read cornea story on was the FDA’s rejection of Eton Pharmaceuticals’ allergic conjunctivitis treatment candidate EM-100.Here are the to...

Click here to view the full article which appeared in Opthalmology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.